Home > Insider Trading > Filing (0001179110-19-009744)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1650664	Editas Medicine Inc.	EDIT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1405692	Cynthia Collins	C/O Editas Medicine, Inc. 11 Hurley St. Cambridge MA 02141	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-08-19	8,283	$0.00	16,566	No	4	A	Direct
Common Stock	Disposition	2019-08-19	5,193	$25.83	11,373	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

The reported transaction involved the Reporting Peron's receipt of 8,283 shares of common stock on August 19, 2019 in connection with the vesting of a restricted stock unit award. Such amount includes (i) 8,283 shares of common stock received by the Reporting Person on August 19, 2019 that was previously reported on Table II of a Form 4 filed by the Reporting Person with the SEC on February 4, 2019 and (ii) 8,283 shares of common stock received by the Reporting Person in connection with a restricted stock unit award that was previously reported in Table 1 of a Form 4 filed by the Reporting Person with the SEC on August 7, 2019.
The sales reported in this Form 4 were effected pursuant to a durable automatic sales instruction letter entered into between the Reporting Person and the issuer in connection with the Reporting Person receiving restricted stock unit awards from the issuer, and represent the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 19, 2019. The sales do not represent a discretionary trade by the Reporting Person.